PRNewsWire - Health

Lovet Pet Health Care Launches in Michigan to Expand Access as New Survey Reveals Cost Barriers for Pet Parents
Le-Vel Hosts Powerful eLeVate 2025 Event with New Premium Product Launches, Recognition, and Unforgettable Inspiration
Akeso's Ebdarokimab ( IL - 12/IL - 23 Dual - Targeted Monoclonal Antibody) Approved in China for Moderate - to - Severe Plaque Psoriasis
So-Young International Inc. Files Its Annual Report on Form 20-F